ELAN
Price
$14.64
Change
-$0.08 (-0.54%)
Updated
Jul 3 closing price
Capitalization
7.87B
37 days until earnings call
KMDA
Price
$7.88
Change
+$0.14 (+1.81%)
Updated
Jul 3 closing price
Capitalization
306.49M
39 days until earnings call
Interact to see
Advertisement

ELAN vs KMDA

Header iconELAN vs KMDA Comparison
Open Charts ELAN vs KMDABanner chart's image
Elanco Animal Health
Price$14.64
Change-$0.08 (-0.54%)
Volume$2.01M
Capitalization7.87B
Kamada
Price$7.88
Change+$0.14 (+1.81%)
Volume$23.33K
Capitalization306.49M
ELAN vs KMDA Comparison Chart in %
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. KMDA commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Buy and KMDA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ELAN: $14.64 vs. KMDA: $7.88)
Brand notoriety: ELAN: Notable vs. KMDA: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 33% vs. KMDA: 31%
Market capitalization -- ELAN: $7.87B vs. KMDA: $306.49M
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. KMDA’s [@Pharmaceuticals: Other] market capitalization is $306.49M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whileKMDA’s FA Score has 1 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • KMDA’s FA Score: 1 green, 4 red.
According to our system of comparison, KMDA is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 5 TA indicator(s) are bullish while KMDA’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 5 bullish, 3 bearish.
  • KMDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than KMDA.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а +2.38% price change this week, while KMDA (@Pharmaceuticals: Other) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

ELAN is expected to report earnings on Aug 11, 2025.

KMDA is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($7.87B) has a higher market cap than KMDA($306M). KMDA YTD gains are higher at: 33.100 vs. ELAN (20.892). KMDA has higher annual earnings (EBITDA): 22.4M vs. ELAN (-224M). ELAN has more cash in the bank: 352M vs. KMDA (55.6M). KMDA has less debt than ELAN: KMDA (8.82M) vs ELAN (5.77B). ELAN has higher revenues than KMDA: ELAN (4.42B) vs KMDA (143M).
ELANKMDAELAN / KMDA
Capitalization7.87B306M2,573%
EBITDA-224M22.4M-1,000%
Gain YTD20.89233.10063%
P/E RatioN/A37.43-
Revenue4.42B143M3,089%
Total Cash352M55.6M633%
Total Debt5.77B8.82M65,450%
FUNDAMENTALS RATINGS
ELAN vs KMDA: Fundamental Ratings
ELAN
KMDA
OUTLOOK RATING
1..100
2413
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
8180
PRICE GROWTH RATING
1..100
4140
P/E GROWTH RATING
1..100
9328
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KMDA's Valuation (73) in the Biotechnology industry is in the same range as ELAN (92) in the Agricultural Commodities Or Milling industry. This means that KMDA’s stock grew similarly to ELAN’s over the last 12 months.

KMDA's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that KMDA’s stock grew similarly to ELAN’s over the last 12 months.

KMDA's SMR Rating (80) in the Biotechnology industry is in the same range as ELAN (81) in the Agricultural Commodities Or Milling industry. This means that KMDA’s stock grew similarly to ELAN’s over the last 12 months.

KMDA's Price Growth Rating (40) in the Biotechnology industry is in the same range as ELAN (41) in the Agricultural Commodities Or Milling industry. This means that KMDA’s stock grew similarly to ELAN’s over the last 12 months.

KMDA's P/E Growth Rating (28) in the Biotechnology industry is somewhat better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that KMDA’s stock grew somewhat faster than ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANKMDA
RSI
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
68%
Momentum
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 26 days ago
67%
Declines
ODDS (%)
Bearish Trend 6 days ago
74%
Bearish Trend 23 days ago
67%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
65%
Aroon
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBL29.530.20
+0.68%
PGIM Portfolio Ballast ETF
SJLD25.060.09
+0.35%
SanJac Alpha Low Duration ETF
VERS52.92N/A
N/A
ProShares Metaverse ETF
TSLR18.49-0.07
-0.38%
GraniteShares 2x Long TSLA Daily ETF
YINN39.39-1.35
-3.31%
Direxion Daily FTSE China Bull 3X ETF

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with ZTS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
-0.54%
ZTS - ELAN
48%
Loosely correlated
+0.06%
VTRS - ELAN
46%
Loosely correlated
-0.21%
PAHC - ELAN
40%
Loosely correlated
+0.21%
AMRX - ELAN
33%
Loosely correlated
+0.60%
OGI - ELAN
33%
Poorly correlated
+3.62%
More

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and OGI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+1.81%
OGI - KMDA
30%
Poorly correlated
+3.62%
RDY - KMDA
28%
Poorly correlated
+1.34%
AMRX - KMDA
26%
Poorly correlated
+0.60%
ELAN - KMDA
24%
Poorly correlated
-0.54%
HROW - KMDA
24%
Poorly correlated
+3.86%
More